PLUS1
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
|
Pre-Market Last Trade |
Last $ 0.41 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ocugen Inc | OCGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 0.4111 | 0.00 | 0.00 | 0.00 | 0.4111 | 07:32:09 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.405 | 0.4185 | 0.0135 | 3.23% | - | - |
| Stock Trades | Traded Volume | Average Volume | 52 Week Range |
|---|---|---|---|
| 3 | 2,781 | 2,771,319 | 0.4001 - 3.35 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 07:13:39 | formt | 2,400 | $ 0.4111 | USD |
Ocugen Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 6.58M | 16.00M | -60.00 | - | 15.52M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 18.00 | 4.00% |
Ocugen News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/08/2019 | 07:30 | GlobeNewswire Inc. | Ocugen Provides Business Update and Third Quarter 2019.. |
| 11/06/2019 | 09:01 | GlobeNewswire Inc. | Ocugen Announces Warrant Restructuring |
| 11/04/2019 | 07:30 | GlobeNewswire Inc. | Ocugen Announces Appointments to Retina Disease and Ocular.. |
| 10/25/2019 | 07:30 | GlobeNewswire Inc. | Ocugen to Host Conference Call on Friday, November 8 at 8:30.. |
| 10/23/2019 | 08:30 | GlobeNewswire Inc. | Ocugen Appoints Jessica Crespo, CPA, as Controller |
| 10/09/2019 | 07:30 | GlobeNewswire Inc. | Ocugen Announces Share Repurchase Program |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OCGN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.834 | 0.84 | 0.4001 | 0.5377025 | 4,048,983 | -0.4229 | -50.71% |
| 1 Month | 1.98 | 2.05 | 0.4001 | 0.8791501 | 1,885,020 | -1.57 | -79.24% |
| 3 Months | 3.24 | 3.35 | 0.4001 | 1.44 | 2,708,074 | -2.83 | -87.31% |
| 6 Months | 3.24 | 3.35 | 0.4001 | 1.44 | 2,708,074 | -2.83 | -87.31% |
| 1 Year | 3.24 | 3.35 | 0.4001 | 1.44 | 2,708,074 | -2.83 | -87.31% |
| 3 Years | 3.24 | 3.35 | 0.4001 | 1.44 | 2,708,074 | -2.83 | -87.31% |
| 5 Years | 3.24 | 3.35 | 0.4001 | 1.44 | 2,708,074 | -2.83 | -87.31% |
Ocugen Description
| Ocugen Inc is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. |
